Skip to main content
. 2007 May;24(5):317–321. doi: 10.1136/emj.2006.038695

Table 1 Baseline characteristics of the two treatment groups.

Variables Salbutamol (n = 28) Formoterol (n = 32)
Sex (M/F) 14/18 13/15
Age (years), mean (SD) 53.2 (15.0) 56.4 (14.2)
Duration of asthma (years), mean (SD) 12.4 (8.4) 10.4 (8.1)
PEFR at baseline (l/min) 100.8 119.3

F, female; M, male; PEFR, peak expiratory flow rate.